Evaluation of anti α-d-Glc<i>p</i>-(1→4)-α-d-Glc<i>p</i> (GAGA4) IgM antibodies as a biomarker for multiple sclerosis.

RSC Adv · 2018 · PMC9084297 · PMID 35542693

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

trending towards significancep = 0.056so close (0.05 < p ≤ 0.1)

Instead, a lower level of these antibodies was observed when compared to HC, with this difference trending towards significance ( p = 0.056) when serum samples were used.

also in 515 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.